Nitrogen

Description

Air Liquide Nitrogen, also known as Azote, is a compressed gas. It is utilized in various industrial applications due to its inert properties. The chemical formula for nitrogen is N₂, and it is characterized by its colorless, odorless, and tasteless nature. As a compressed gas, it is stored under high pressure in appropriate containers for safe handling and use.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. The specific indications and usage details are not provided in the available documentation.

There are no documented teratogenic effects associated with this drug, nor are there any statements regarding potential fetal harm. Additionally, the absence of nonteratogenic effects or related assertions regarding fetal safety is noted.

Healthcare professionals are advised to consider the overall clinical context when prescribing this medication, as specific indications may vary based on individual patient needs and circumstances.

Dosage and Administration

The active ingredient, nitrogen, is to be administered via inhalation. The recommended strength is 992 mL in a 1 L solution. Healthcare professionals should ensure that the administration is performed using appropriate inhalation techniques to achieve optimal delivery of the medication.

Contraindications

Use of this product is contraindicated in situations where safety precautions have not been read and understood. Additionally, it should only be used and stored outdoors or in a well-ventilated area to mitigate potential risks associated with inadequate ventilation. The label must not be removed, as it contains essential safety information.

Warnings and Precautions

WARNING: This product contains gas under pressure and may explode if heated. It has the potential to displace oxygen, leading to rapid suffocation. Healthcare professionals must ensure that all safety precautions are thoroughly read and understood prior to handling. It is imperative to use and store this product exclusively outdoors or in a well-ventilated area. A backflow preventive device should be utilized in the piping, and only equipment rated for cylinder pressure should be employed. The valve must be closed after each use and when the cylinder is empty. Additionally, protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). It is essential to read and follow the Safety Data Sheet (SDS) before use.

In the event of inhalation, immediate action is required. The affected individual should be removed to fresh air and kept comfortable for breathing. Medical advice or attention should be sought promptly.

No specific laboratory tests are recommended for the safe use of this product. However, healthcare professionals should remain vigilant and prepared to provide emergency medical assistance as needed. In case of any adverse effects or concerns, it is advisable to seek medical advice or attention without delay. There are no specific instructions provided for discontinuation or to contact a physician.

Side Effects

Patients should be aware that the product contains gas under pressure, which may pose serious risks, including the potential for explosion if heated. Additionally, the gas may displace oxygen, leading to rapid suffocation.

In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice and attention should be sought immediately to address any complications that may arise from exposure.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use has not been specifically addressed in the provided drug insert. There are no recommended ages, dosing differences, safety concerns, or special precautions for children mentioned. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pediatric patients, as the efficacy and safety profile in this population remains undefined.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including age considerations, dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful monitoring and individualized assessment of treatment risks and benefits in this population.

Pregnancy

The safety and efficacy of this drug during pregnancy have not been established, as it has not been approved by the FDA. There are no specific statements regarding the use of this drug in pregnant patients, nor are there any documented safety concerns, dosage modifications, or special precautions related to its use during pregnancy. Healthcare professionals should exercise caution and consider the potential risks when prescribing this medication to women of childbearing potential. It is advisable to weigh the benefits against any unknown risks to fetal outcomes.

Lactation

The safety and effectiveness of this drug have not been established in nursing mothers. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this drug to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically studied in relation to dosage adjustments, special monitoring, or safety considerations. Therefore, there is no available information regarding the use of this medication in individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

Overdosage of nitrogen gas can result in rapid suffocation, primarily due to the displacement of oxygen in the environment. This condition poses a significant risk to the affected individual, necessitating immediate action.

In the event of nitrogen gas overdosage, it is crucial to promptly remove the individual from the contaminated area to a location with fresh air. Ensuring the person is comfortable while breathing is essential for their recovery.

Healthcare professionals should be alerted immediately, and medical advice or attention must be sought without delay. Timely intervention is vital to mitigate the risks associated with nitrogen gas overdosage and to ensure the safety and well-being of the affected individual.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the product contains gas under pressure, which may pose a risk of explosion if heated. It is crucial to inform patients that the gas may displace oxygen and lead to rapid suffocation. Patients must be instructed not to handle the product until they have read and understood all safety precautions.

Patients should be reminded to use and store the product only outdoors or in a well-ventilated area. It is important to emphasize the necessity of using a backflow preventive device in the piping and to utilize only equipment that is rated for cylinder pressure. Patients should be counseled to close the valve after each use and when the cylinder is empty.

Additionally, patients should be informed to protect the product from sunlight when the ambient temperature exceeds 52°C (125°F). They should be encouraged to read and follow the Safety Data Sheet (SDS) before use to ensure safe handling.

In the event of inhalation, patients should be instructed to remove themselves to fresh air and maintain a comfortable position for breathing. They should seek medical advice or attention if necessary. It is also important to remind patients not to remove the label from the product, as it contains essential safety information.

Storage and Handling

The product is supplied in a manner that ensures safe handling and storage. It is essential to use and store the product exclusively outdoors or in a well-ventilated area to prevent the accumulation of hazardous vapors.

When ambient temperatures exceed 52°C (125°F), the product must be protected from direct sunlight to maintain its integrity and safety. After each use, and when the product is empty, the valve should be securely closed to prevent any unintended release.

Additionally, it is crucial to utilize a backflow preventive device in the piping to ensure safe operation. The equipment used with this product must be rated for cylinder pressure to guarantee safe handling and prevent accidents.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Air Liquide Canada Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)